GLS-5310 Vaccine

GLS-5310 · GeneOne Life Science, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLS-5310 Vaccine, covering 2025-09-03 to 2025-09-03. Get the full timeline:

Most recent: Clinical Trial Update: GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19) [Phase 1, Phase 2]